public traded as nasdaq endp s & p 500 component industry pharmaceutical headquarters dublin ireland and malvern pennsylvania u.s. website www.endo.com endo international plc is global specialty healthcare company . it was created as a result of a management buyout from dupont merck in 1997 . three dupont merck executives carol a. ammon chairman president & ceo and mariann t. macdonald executive vice president operations along with another colleague purchased all of endo laboratories l.l.c. s generic products along with 12 important brand products including percocet percodan and opana . the new company was called endo pharmaceuticals inc. endo acquired algos pharmaceutical corporation through a merger in july 2000 and began to trade publicly nasdaq endp . endo successfully completed a secondary offering for a total of 12 925 000 shares of its common stock in oct 2001 . the net proceeds were used to pay existing bank debt . on february 28 2014 endo completed its acquisition of paladin labs a leading canada based specialty pharmaceutical company . endo and paladin labs came together under endo international plc and endo established new global headquarters in dublin ireland . endo develops manufactures markets and distributes quality branded pharmaceutical generic and device products though its operating companies . the company has global headquarters in dublin ireland and u.s. headquarters in malvern pa . contents 1 corporate governance 2 products 3 acquisitions 3.1 acquisition attempts 4 mesh litigation and liabilities 5 references 6 external links corporate governance edit as of march 2013 update 1 endo s chief executive officer ceo was rajiv de silva . 2 as of september 2013 update endo s chief financial officer cfo was suketu upadhyay . citation needed a prior cfo charles a. rowland jr. had been appointed in december 2006 . 2 products edit amantadine symmetrel carbidopa with levodopa carbidopa levodopa usp frovatriptan frova hydrocodone with acetaminophen zydone hydrocodone with homatropine hycodan lidocaine lidoderm lidocaine with tetracaine synera molindone moban oxycodone with acetaminophen percocet endocet oxycodone with aspirin percodan oxymorphone opana fortesta source 3 endo pharmaceuticals once had the united states marketing rights for the fda approved synera anesthetic patch for needle procedures . the agreement of 6 january 2006 for endo pharmaceuticals to market synera lidocaine plus tetracaine patch was terminated on 31 july 2008 . endo is no longer involved with the synera patch in the united states . zars pharmaceuticals was the patent holder for synera . 4 the rights to synera passed to nuvo research of canada in may 2011 upon the acquisition of zars pharmaceuticals by nuvo research . 5 upon its purchase of paladin labs of montreal endo once again became involved with the synera patch by acquiring the rights to market synera in canada upon the approval of the synera patch by health canada . 6 7 acquisitions edit in 2009 endo bought indevus pharmaceuticals to diversify into endocrinology and oncology . 8 the company entered the male hypogonadism market later in 2010 with fortesta 2 % gel . 8 on november 4 2010 endo acquired penwest pharmaceuticals . on december 1 2010 endo acquired generics company qualitest pharmaceuticals . on june 20 2011 endo acquired medical device company american medical systems inc ams . in november 2013 endo agreed to purchase paladin labs inc for about 1.6 billion to gain access to the canadian market as well as expand into emerging markets . 7 the acquisition was finalized february 2014 . on february 3 2014 endo successfully completed its acquisition of specialty generics company boca pharmacal . on july 24 2014 endo completed its purchase of somar a privately owned specialty pharmaceuticals company based in mexico city . in august 2014 endo completed its purchase of dava pharmaceuticals inc. a privately held generic pharmaceuticals manufacturer . in october 2014 endo international said it would buy auxilium pharmaceuticals for 2.6 billion . 9 that transaction was completed by january 2015 the company said in dublin 10 after receiving all the regulatory approvals the deal needed . acquisition attempts edit in early 2014 endo sought to acquire nupathe a speciality pharmaceutical developer for us 105 000 000 . 11 however teva prevailed in this acquisition with a substantially higher bid . 12 mesh litigation and liabilities edit with the acquisition of american medical systems inc ams endo accepted to settle mesh claims . the mesh liabilities have ballooned to billions since even after settling thousands of claims . references edit management team . about us . endo pharmaceuticals . rajiv de silva . retrieved 2015 08 05 . self published source a b staff 6 december 2006 . endo pharmaceuticals names new cfo . the news journal . delaware . retrieved 2015 08 05 . subscription required product listing . endo pharmaceuticals . 2006 . retrieved 2006 12 06 . http www.wikinvest.com stock endo pharmaceuticals holdings % 28endp % 29 zars % 20pharma http www.prnewswire.com news releases nuvo research completes its acquisition of zars pharma 121767618.html http www.marketwired.com press release paladin labs nuvo research sign canadian license agreement synera loan agreement tsx plb 1662022.htm a b bloomberg 2013 11 04 . endo to buy paladin labs . bloomberg . retrieved 2013 11 04 . a b associated press 2009 01 06 . endo to buy indevus . the boston globe . retrieved 2009 06 28 . http www.genengnews.com gen news highlights endo scores with 2 6b offer for auxilium which ends qlt deal 81250454 endo completes acquisition of auxilium pharmaceuticals endo corporate website 29 january 2015 . retrieved 9 may 2016 . endo to purchase nupahte for 150m . news industry watch . gen. eng . biotechnol . news paper format requires url help . 34 2 . january 15 2014 . p. 10 . teva outbids endo acquires nupathe for 144m . news industry watch . gen. eng . biotechnol . news paper . 34 4 . february 15 2014 . p. 10 . corporate officers . endo pharmaceuticals . 2008 . retrieved 2008 09 15 . external links edit official website v t e pharmaceutical companies of the united states abbott laboratories acorda therapeutics actavis aderis pharmaceuticals adolor corporation alcon alexion pharmaceuticals alkermes allergan alza amgen amylin pharmaceuticals ariad pharmaceuticals aryx therapeutics avax technologies baxter international biocryst pharmaceuticals biogen biolex biovest biovista bradley pharmaceuticals bristol myers squibb cancervax century pharmaceuticals cephalon ceragenix pharmaceuticals combe incorporated cortex pharmaceuticals cotherix covance covidien cubist pharmaceuticals cutter laboratories cytosport cytrx danco laboratories dnaprint genomics epix pharmaceuticals eli lilly and company elorac endo pharmaceuticals ethicon endo surgery ethicon inc. forest laboratories galena biopharma genvec genentech genta gilead sciences hospira imclone systems institute for oneworld health intercept pharmaceuticals ista pharmaceuticals ivax corporation janssen biotech johnson & johnson kinetic concepts king pharmaceuticals kinray kv pharmaceutical leiner health products mallinckrodt martek biosciences corporation s. e. massengill company mckesson corporation mcneil laboratories melior discovery mentholatum merck & co. miles laboratories mylan myriad genetics naurex nereus pharmaceuticals northwest biotherapeutics norwich pharma services novabay pharmaceuticals nuvelo organon international ortho pharmaceutical ortho mcneil pharmaceutical osi pharmaceuticals ovation pharmaceuticals par pharmaceutical parke davis perrigo pfizer pharmaceutical product development prasco laboratories procter & gamble proteon therapeutics purdue pharma qualitest quark pharmaceuticals regeneron repros therapeutics rib x pharmaceuticals sarepta therapeutics savage laboratories schering plough g. d. searle & company sheffield pharmaceuticals smith kline & french spectrum pharmaceuticals sterling drug tanox tap pharmaceutical products tec laboratories teva pharmaceutical industries tiens biotech group titan pharmaceuticals trevena inc trubion upjohn upsher smith laboratories valeant pharmaceuticals ventria bioscience vertex pharmaceuticals verus pharmaceuticals vion pharmaceuticals inc. viropharma west pharmaceutical services wyeth zonite products corporation list of pharmaceutical companies retrieved from https en.wikipedia.org w index.php title endo international plc & oldid 743230923 categories companies based in chester county pennsylvaniapharmaceutical companies of the united statesamerican companies established in 1997companies in the nasdaq biotechnology indexlife sciences industry1997 establishments in pennsylvaniacompanies based in dublin city hidden categories accuracy disputes from august 2015pages containing links to subscription only contentpages using citations with format and no urlarticles containing potentially dated statements from march 2013all articles containing potentially dated statementsarticles containing potentially dated statements from september 2013all articles with unsourced statementsarticles with unsourced statements from august 2015 navigation menu personal tools not logged intalkcontributionscreate accountlog in namespaces article talk variants views read edit view history more search navigation main pagecontentsfeatured contentcurrent eventsrandom articledonate to wikipediawikipedia store interaction helpabout wikipediacommunity portalrecent changescontact page tools what links hererelated changesupload filespecial pagespermanent linkpage informationwikidata itemcite this page print export create a bookdownload as pdfprintable version languages fran ais edit links this page was last modified on 8 october 2016 at 17 13 . text is available under the creative commons attribution sharealike license ; additional terms may apply . by using this site you agree to the terms of use and privacy policy . wikipedia is a registered trademark of the wikimedia foundation inc. a non profit organization . privacy policy about wikipedia disclaimers contact wikipedia developers cookie statement mobile view